These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26568594)

  • 21. Validation of two simple patient-centered outcome measures for virtual monitoring of patients with idiopathic inflammatory myositis.
    Naveen R; Thakare DR; Agarwal V; Aggarwal R; Gupta L
    Clin Rheumatol; 2022 Mar; 41(3):765-772. PubMed ID: 34791543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinimetric properties of aerobic and anaerobic fitness measures in adults with cerebral palsy: A systematic review of the literature.
    Lennon N; Thorpe D; Balemans AC; Fragala-Pinkham M; O'Neil M; Bjornson K; Boyd R; Dallmeijer AJ
    Res Dev Disabil; 2015; 45-46():316-28. PubMed ID: 26296079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Standard Set of Outcome Domains and Proposed Measures for Chronic Obstructive Pulmonary Disease in Primary Care Physical Therapy Practice in the Netherlands: a Modified RAND/UCLA Appropriateness Method.
    Verburg AC; van Dulmen SA; Kiers H; Ypinga JH; Nijhuis-van der Sanden MW; van der Wees PJ
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2649-2661. PubMed ID: 31819398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the Fitkids exercise therapy program on health-related fitness, walking capacity, and health-related quality of life.
    Kotte EM; de Groot JF; Winkler AM; Huijgen BC; Takken T
    Phys Ther; 2014 Sep; 94(9):1306-18. PubMed ID: 24786945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group.
    Saygin D; Alexanderson H; DiRenzo D; Raaphorst J; de Visser M; Ren D; Regardt M; de Groot I; Sarver C; Kim JY; Lodin K; Beer K; Needham M; Park JK; Christopher-Stine L; Mecoli CA
    Semin Arthritis Rheum; 2024 Aug; 67():152476. PubMed ID: 38851171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies.
    Regardt M; Mecoli CA; Park JK; de Groot I; Sarver C; Needham M; de Visser M; Shea B; Bingham CO; Lundberg IE; Song YW; Christopher-Stine L; Alexanderson H
    J Rheumatol; 2019 Oct; 46(10):1351-1354. PubMed ID: 30770504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study.
    Štorkánová H; Oreská S; Špiritović M; Heřmánková B; Bubová K; Kryštůfková O; Mann H; Komarc M; Slabý K; Pavelka K; Šenolt L; Zámečník J; Vencovský J; Tomčík M
    Front Immunol; 2022; 13():811045. PubMed ID: 35154129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies.
    Rider LG
    Rheum Dis Clin North Am; 2002 Nov; 28(4):935-77. PubMed ID: 12506779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.
    Saygin D; DiRenzo D; Raaphorst J; de Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; de Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-Stine L; Mecoli CA; Park JK;
    Semin Arthritis Rheum; 2024 Feb; 64():152339. PubMed ID: 38141522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
    Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
    Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.
    Braam KI; van der Torre P; Takken T; Veening MA; van Dulmen-den Broeder E; Kaspers GJ
    Cochrane Database Syst Rev; 2013 Apr; (4):CD008796. PubMed ID: 23633361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Reported Outcomes in Adult Idiopathic Inflammatory Myopathies.
    DiRenzo D; Bingham CO; Mecoli CA
    Curr Rheumatol Rep; 2019 Nov; 21(11):62. PubMed ID: 31741079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up.
    Špiritović M; Heřmánková B; Oreská S; Štorkánová H; Růžičková O; Vernerová L; Klein M; Kubínová K; Šmucrová H; Rathouská A; Česák P; Komarc M; Bunc V; Pavelka K; Šenolt L; Mann H; Vencovský J; Tomčík M
    Arthritis Res Ther; 2021 Jun; 23(1):173. PubMed ID: 34154634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies.
    Khadilkar SV; Patil SG; Amin SN
    Neurol India; 2008; 56(3):356-62. PubMed ID: 18974564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis.
    Alemo Munters L; Alexanderson H; Crofford LJ; Lundberg IE
    Curr Rheumatol Rep; 2014 Jul; 16(7):429. PubMed ID: 24879535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
    Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
    Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of ultrasonography in assessing disease activity in patients with idiopathic inflammatory myopathies.
    Sousa Neves J; Santos Faria D; Cerqueira M; Afonso MC; Teixeira F
    Int J Rheum Dis; 2018 Jan; 21(1):233-239. PubMed ID: 28782262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.